期刊文献+

清金糖浆辅助治疗小儿支气管肺炎的疗效观察

Observation of Curative Effect of Qingjin Syrup Adjuvant Treatment of Bronchial Pneumonia in Children
下载PDF
导出
摘要 目的观察清金糖浆辅助治疗小儿支气管肺炎的临床疗效与安全性。方法选择2013年01月—2014年06月期间,在我科住院的198例支气管肺炎患儿,随机分为治疗组104例和对照组94例,对照组严格按照国家卫计委要求进入支气管肺炎基本诊疗路径标准住院流程进行治疗;治疗组在基本诊疗路径的基础上加用清金糖浆治疗。比较两组主要症状、体征的改善情况。结果治疗组显效率71.1%,总有效率97.1%;对照组显效率43.6%,总有效率86.2%;治疗组疗效明显优于对照组(P<0.05)。结论支气管肺炎在基本诊疗路径的基础上加用清金糖浆治疗,能显著改善支气管肺炎患儿的临床主要症状、体征,疗效明显,值得临床推广应用。 Objective To observe the clinical efficacy and safety of qingjin syrup adjunctive therapy in children with bronchial pneumonia. Methods January 2013 - June 2014 period in children hospitalized in our department 198 cases of bronchial pneumonia, 104 cases were randomly divided into treatment group and control group 94 cases, control group in strict accordance with the National Health Planning Commission requested access to bronchial pneumonia basic medical inpatient flow path criteria for treatment; treatment group on the basis of basic medical path on the use of clean golden syrup treatment. Improvement compared to the situation two main symptoms and signs. Results The significantly effective rate and total efficiency rate were both significantly higher in treatment group (71.1%,97.1%) than control group(43.6%, 86.2%, P〈O.05). Conclusion Useing clean golden syrup in the basic treatment of bronchial pneumonia of children, can significantly relieve the main clinical symptoms in children with bronchial pneumonia. It's worthy of clinicnl nnnllenticm
出处 《国外医药(抗生素分册)》 CAS 2015年第3期136-137,共2页 World Notes on Antibiotics
关键词 清金糖浆 小儿支气管肺炎 疗效 qingjin syrup bronchial pneumonia in children efficacy
  • 相关文献

参考文献3

二级参考文献12

  • 1李建国,陈瑞,吕志强,张蔚,江山平,何剑锋.左氧氟沙星与头孢噻肟治疗下呼吸道感染的疗效比较[J].中华医院感染学杂志,2004,14(3):314-316. 被引量:22
  • 2王姣峰,唐平,张传军.左氧氟沙星治疗呼吸道感染的疗效观察[J].中华医院感染学杂志,2004,14(9):1041-1042. 被引量:13
  • 3Karlowsky JA,Thornsberry C,Jones ME,et al.Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States:results from the TRUST Surveillance Program (1998-2002)[J].Clin Infect Dis,2003,36(8):963-970.
  • 4Johnson DM,Stilwell MG,Fritsche TR,et al.Emergence of multidrug-resistant Streptococcus pneumoniae:report from the SENTRY Antimicrobial Surveillance Program (1999-2003)[J].Diagn Microbiol Infect Dis,2006,56(1):69-74.
  • 5Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults[J].Clin Infect Dis,2003,37(11):1405-1433.
  • 6Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention[J].Am J Respir Crit Care Med,2001,163(7):1730-1754.
  • 7Halm EA,Teirstein AS.Clinical practice.Management of community-acquired pneumonia[J].N Engl J Med,2002,347(25):2039-2045.
  • 8Martinez JA,Horcajada JP,Alemla M,et al.Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia[J].Clin Infect Dis,2003,36(4):389-395.
  • 9Marguerite B,Penny A,John D,et al.Antimicrobial susceptibility:nationwide patterns in the TRUST Surveillance Program.Perspectives from specialists in ophthalmology,microbiology,and infectious disease[J].Ophthalmol Times,2006,31(Suppl 9).
  • 10社区获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):199-201. 被引量:1037

共引文献587

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部